
Price
$0.00
无数据
无数据
无数据
| CAS Number | 23651-95-8 |
| Catalog Number | AG002O25(AGN-PC-0QZT7K) |
| Chemical Name | L-Tyrosine, β,3-dihydroxy-, (βR)- |
| EC Number | 223-480-5 |
| IUPAC Name | (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid |
| InChI | InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1 |
| InChI Key | QXWYKJLNLSIPIN-JGVFFNPUSA-N |
| MDL Number | MFCD00799030 |
| Molecular Formula | C9H11NO5 |
| Molecular Weight | 213.1873 |
| SMILES | c1cc(c(cc1[C@H]([C@@H](C(=O)O)N)O)O)O |
| UNII | J7A92W69L7 |
| Synonyms | 3,4 Dihydroxyphenylserine,
3,4 threo DOPS,
3,4-Dihydroxyphenylserine,
3,4-threo-DOPS,
DL threo 3,4 Dihydroxyphenylserine,
DL-threo-3,4-Dihydroxyphenylserine,
Droxidopa,
Droxidopa, (DL-Tyr)-Isomer,
erythro 3,4 Dihydroxyphenylserine,
erythro-3,4-Dihydroxyphenylserine,
threo DOPS,
threo-DOPS,
droxidopa,
23651-95-8,
L-DOPS,
Northera,
DOPS,
(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid,
threo-Dopaserine,
3916-18-5,
DL-threo-DOPS,
L-Threodops,
DL-threo-3,4-Dihydroxyphenylserine,
DL-threo-Droxidopa,
DL-threo-Dihydroxyphenylserine,
UNII-J7A92W69L7,
SM 5688,
CHEBI:31524,
Droxidopa (L-DOPS),
threo-beta,3-Dihydroxy-DL-tyrosine,
EINECS 223-480-5,
beta,3-Dihydroxy-DL-tyrosine threo-,
BRN 2852792,
L-threo-dihydroxyphenylserine,
DL-threo-3-(3,4-Dihydroxyphenyl)serine,
Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-,
J7A92W69L7,
Droxidopa [Latin],
L-dihydroxyphenylserine,
threo-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic acid,
DL-threo-beta-(3,4-Dihydroxyphenyl)serine,
H-DL--(3,4-Dihydroxyphenyl)-DL-Ser-OH,
3,4-Dihydroxyphenylserine,
L-Tyrosine, beta,3-dihydroxy-, threo-,
Norethra,
(2RS,3RS)-2-AMINO-3-(3,4-DIHYDROXY-PHENYL)-3-HYDROXY-PROPIONIC ACID,
(2RS,3RS)-2-Amino-3-(3,4-dihydroxy-phenyl)-3-hydroxy-propionic acid;DL-DOPS;DL-Droxidopa,
L-threo-3-(3,4-Dihydroxyphenyl)serine,
(-)-(2S,3R)-2-Amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propionic acid,
droxidopum,
Droxidopa [USAN:INN:JAN],
MFCD00004266,
threo-b,3-dihydroxy-l-tyrosine,
droxidopa-l-dops,
Northera (TN),
492-46-6,
L-threo DOPS,
L-threo-DOPS,
Dops (TN),
(-)-threo-3-(3,4-Dihydroxyphenyl)-L-serine,
Serine, 3-(3,4-dihydroxyphenyl)-, L-threo-,
AC1Q5QIU,
Droxidopa (JP17/INN),
1-14-00-00685 (Beilstein Handbook Reference),
SCHEMBL134299,
AC1L3P81,
GTPL7391,
CHEMBL2103827,
CTK8B7488,
QXWYKJLNLSIPIN-JGVFFNPUSA-N,
D,L-(3,4-Dihydroxyphenyl)serine,
Droxidopa (L-DOPS,SM-5688),
L-threo 3,4-Dihydroxyphenylserine,
BCP06516,
KS-00000ZU4,
ZINC1482049,
ANW-57465,
BDBM50103611,
MFCD00799030,
s3041,
SM5688,
(betaR)-beta,3-dihydroxy-L-tyrosine,
L-DOPS, >=98% (HPLC),
(2S,3R)-3,4-dihydroxy-phenylserine,
AKOS015889899,
API0002500,
CCG-222060,
CS-2468,
DB06262,
SM-5688,
BC214748,
DL-Tyrosine, beta,3-dihydroxy-, threo-,
HY-13458,
DL-threo-|A-(3,4-Dihydroxyphenyl)serine,
AX8126964,
L-Tyrosine, beta,3-dihydroxy-, (betaR)-,
LS-145005,
TC-146210,
D4235,
FT-0651749,
FT-0667809,
D01277,
AB01566868_01,
DL-Tyrosine, beta,3-dihydroxy-, threo- (9CI),
916A185,
SR-01000883755,
Droxidopa (L-threo-3-(3,4-Dihydroxyphenyl)serine),
L-Tyrosine, beta,3-dihydroxy-, (beta-R)- (9CI),
Q-201050,
SR-01000883755-1,
UNII-24A0V01WKS component QXWYKJLNLSIPIN-JGVFFNPUSA-N,
23651-95-8,1260173-94-1(HCl),
(2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic Acid,
(-)-(2S,3R)-2-amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid,
(2RS,3RS)-2-AMINO-3-(3,4-DIhydroxyphenyl)-3-HYDROXY-propanoic acid,
(2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic Acid / L-threo-3,4-Dihydroxyphenylserine,
Droxydopa,
threo DOPS,
threo-DOPS,
3,4 threo DOPS,
3,4-threo-DOPS,
Threo-dihydroxyphenylserine,
Droxidopa [INN:JAN],
UNII-24A0V01WKS,
3,4 Dihydroxyphenylserine,
D0I3RO,
Droxidopa, (DL-Tyr)-Isomer,
L-threo-3,4-dihydroxyphenylserine,
24A0V01WKS,
C9H11NO5,
erythro 3,4 Dihydroxyphenylserine,
erythro-3,4-Dihydroxyphenylserine,
C9-H11-N-O5,
CID92974,
DL threo 3,4 Dihydroxyphenylserine,
AR-1L6839,
(beta R)-beta,3-Dihydroxy-L-tyrosine,
DL-Tyrosine, .beta.,3-dihydroxy-, threo-,
H-DL-b-(3,4-Dihydroxyphenyl)-DL-Ser-OH,
B1738,
-2-AMINO-3- -3-HYDROXY-PROPIONICACID,
D015103,
6319-77-3,
|
| Complexity | 235 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 213.064g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 15 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 213.189g/mol |
| Monoisotopic Mass | 213.064g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 124A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -3.2 |
| Symbol: | |
| Hazard statements | |
| Precuationary statements | |
| Siginal words | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

